Publicaciones en colaboración con investigadores/as de University of Leeds (19)

2024

  1. A new framework for the diagnosis, staging and management of obesity in adults

    Nature Medicine

2023

  1. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

    The Lancet Oncology, Vol. 24, Núm. 6, pp. e255-e269

  2. Processed Electroencephalogram-Based Monitoring to Guide Sedation in Critically Ill Adult Patients: Recommendations from an International Expert Panel-Based Consensus

    Neurocritical Care, Vol. 38, Núm. 2, pp. 296-311

2022

  1. ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma

    Transplantation and Cellular Therapy, Vol. 28, Núm. 6, pp. 284-293

  2. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Silencing of histone deacetylase 6 decreases cellular malignancy and contributes to primary cilium restoration, epithelial-to-mesenchymal transition reversion, and autophagy inhibition in glioblastoma cell lines

    Biology, Vol. 10, Núm. 6

  2. Vaccinating People with Obesity for COVID-19: EASO Call for Action

    Obesity Facts, Vol. 14, Núm. 3, pp. 334-335

2020

  1. European Association for the Study of Obesity Position Statement on the Global COVID-19 Pandemic

    Obesity Facts, Vol. 13, Núm. 2, pp. 292-296

  2. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

    Radiotherapy and Oncology

  3. Obesity and COVID-19: The Two Sides of the Coin

    Obesity Facts, Vol. 13, Núm. 4, pp. 430-438

  4. Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 1

    HEMATO

2019

  1. Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery

    British Journal of Anaesthesia, Vol. 122, Núm. 2, pp. 170-179

  2. Semaglutide as a promising antiobesity drug

    Obesity Reviews, Vol. 20, Núm. 6, pp. 805-815

2018

  1. Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 33, Núm. 2, pp. ii4-ii14

2017

  1. Variations in the Prevalence of Obesity among European Countries, and a Consideration of Possible Causes

    Obesity Facts, Vol. 10, Núm. 1, pp. 25-37

2016

  1. Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): A randomised, double-blind, placebo-controlled phase 3 trial

    The Lancet, Vol. 387, Núm. 10023, pp. 1066-1074

  2. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2014

  1. Beyond BMI - Phenotyping the obesities

    Obesity Facts, Vol. 7, Núm. 5, pp. 322-328

2003

  1. Identification and characterization of a natural R96CEPCR variant

    Journal of Thrombosis and Haemostasis